- Rank in Search Criteria: 4221
World Rank (Jan-05-2024): 14,116
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 14011
Market Cap (Jul-30-2023): 0.41 Billion USD
World Rank (Jan-2022): 16,512
Market Cap (Jan-2022): 0.31 Billion USDAnnual Revenue in USD: 183 Million USD
Annual Net Income in USD: 17 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 4222
World Rank (Jan-05-2024): 14,117
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 16127
Market Cap (Jul-30-2023): 0.29 Billion USD
World Rank (Jan-2022): 16,822
Market Cap (Jan-2022): 0.29 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4223
World Rank (Jan-05-2024): 14,118
World Rank (Jul-30-2023): 14118
World Rank (Jan-2022): 14,118
Market Cap (Jan-2022): 0.45 Billion USDHeadquarters Country: USA Annual Revenue in USD: 352 Million USD
Annual Net Income in USD: 15 Million USD
Annual Results for Period ending: Dec-2020 ending yearEmployee Count: 1,910
Employee Count as of Date: As on 2020
- Rank in Search Criteria: 4224
World Rank (Jan-05-2024): 14,123
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 14495
Market Cap (Jul-30-2023): 0.38 Billion USD
World Rank (Jan-2022): 17,099
Market Cap (Jan-2022): 0.28 Billion USDCompany Profile: The Westaim Corporation (TSXV: WED) is a Canadian investment company specializing in providing long-term capital to businesses operating primarily within the global financial services industry. Headquarters is in Canada.
- Rank in Search Criteria: 4225
World Rank (Jan-05-2024): 14,126
World Rank (Jul-30-2023): 14126
Market Cap (Jul-30-2023): 0.40 Billion USD
World Rank (Jan-2022): 17,388
Market Cap (Jan-2022): 0.27 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4226
World Rank (Jan-05-2024): 14,130
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 13980
Market Cap (Jul-30-2023): 0.41 Billion USD
World Rank (Jan-2022): 11,933
Market Cap (Jan-2022): 0.64 Billion USDHeadquarters Country: USA Annual Revenue in USD: 193 Million USD
Annual Net Income in USD: 189 Million USD
Annual Results for Period ending: Oct-2021 ending year
- Rank in Search Criteria: 4227
World Rank (Jan-05-2024): 14,133
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 14172
Market Cap (Jul-30-2023): 0.40 Billion USD
World Rank (Jan-2022): 16,569
Market Cap (Jan-2022): 0.31 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4228
World Rank (Jan-05-2024): 14,137
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 13592
Market Cap (Jul-30-2023): 0.44 Billion USD
World Rank (Jan-2022): 10,330
Market Cap (Jan-2022): 0.85 Billion USDHeadquarters Country: USA Annual Revenue in USD: 498 Million USD
Annual Net Income in USD: 45 Million USD
Annual Results for Period ending: Jan-2022 ending yearEmployee Count: 778
Employee Count as of Date: As on 2021
- Rank in Search Criteria: 4229
World Rank (Jan-05-2024): 14,138
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 12951
Market Cap (Jul-30-2023): 0.49 Billion USD
World Rank (Jan-2022): 13,051
Market Cap (Jan-2022): 0.53 Billion USDHeadquarters Country: USA Annual Revenue in USD: 0 Million USD
Annual Net Income in USD: -87 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 87
Employee Count as of Date: As on 2021
Company Profile: Lexicon Pharmaceuticals is a Biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize winning technology to discover and develop precise medicines for people with serious, chronic conditions. The company annual revenue is 322.07 million USD and 202 employees as on 2019. The headquarters is in USA.
- Rank in Search Criteria: 4230
World Rank (Jan-05-2024): 14,150
Market Cap (Jan-05-2024): 0.39 Billion USD
World Rank (Jul-30-2023): 14254
Market Cap (Jul-30-2023): 0.39 Billion USD
World Rank (Jan-2022): 15,427
Market Cap (Jan-2022): 0.37 Billion USDHeadquarters Country: USA